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Lipid lateral organization in binary-constituent monolayers consisting of ﬂuorescent and nonﬂuorescent lipids has been
investigated by acquiring multiple emission spectra during measurement of each force-area isotherm. The emission spectra
reﬂect BODIPY-labeled lipid surface concentration and lateral mixing with diﬀerent nonﬂuorescent lipid species. Using principal
component analysis (PCA) each spectrum could be approximated as the linear combination of only two principal vectors. One
point on a plane could be associated with each spectrum, where the coordinates of the point are the coeﬃcients of the linear
combination. Points belonging to the same lipid constituents and experimental conditions form a curve on the plane, where each
point belongs to a diﬀerent mole fraction. The location and shape of the curve reﬂects the lateral organization of the ﬂuorescent
lipid mixed with a speciﬁc nonﬂuorescent lipid. The method provides massive data compression that preserves and emphasizes
key information pertaining to lipid distribution in diﬀerent lipid monolayer phases. Collectively, the capacity of PCA for handling
large spectral data sets, the nanoscale resolution aﬀorded by the ﬂuorescence signal, and the inherent versatility of monolayers for
characterizationoflipidlateralinteractionsenablesigniﬁcantlyenhancedresolutionoflipidlateralorganizationalchangesinduced
by diﬀerent lipid compositions.
1.Introduction
Biomembranes contain a variety of diﬀerent lipids with
a broad array of physicochemical properties. Such lipid
variety has stimulated ideas regarding the existence of
nonrandom lateral organizational states, including the so-
called raft microdomains [1–7]. Model membranes, that
is, bilayer vesicles and monolayer ﬁlms, have proven useful
for dissection of the lipid lateral distributional tendencies
because simple combinations are possible and adjustments
to lipid composition are relatively straightforward. With
lipid monolayer systems, imaging of the monolayer surfaces
to obtain direct insights into lipid lateral organizational
states at macroscopic levels, that is, micron resolution,
can be achieved using epiﬂuorescence and/or Brewster
angle microscopy [7–10]. These approaches have provided
fundamental insights into the role(s) played by line tension
and other parameters in stabilizing lipid macrodomains.
However, their resolution capabilities are constrained to the
micron range, limiting their eﬀectiveness for detection of
microdomains.
Recently, we showed that nanoscale changes in lipid
packing and lateral organization can be detected in mixed
monolayers of 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
choline (POPC) and 1-palmitoyl-2-[7-(4, 4-diﬂuoro-
1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-yl) he-
ptanoyl]-sn-glycero-3-phosphocholine (Me4BODIPY-PC)
by direct monitoring of changes in ﬂuorescence emission2 International Journal of Biomedical Imaging
from multiple spectra acquired simultaneously with the
force-area isotherms [11, 12]. Me4BODIPY-PC mimics
the behavior of ﬂuid-phase PCs with unsaturated acyl
chains and does not perturb lipid packing when the
ﬂuorophore concentration is kept low (e.g., ≤1m o l e % ) .
At higher mole fractions (e.g., 10 or 20 mole%), the
probe begins to exert its own inﬂuence on the system
rather than serving as a completely “impartial” reporter, a
feature observed for virtually all probe molecules. Spectral
characterization of Me4BODIPY-PC incorporated into lipid
monolayers and bilayers indicates retention of excitation
and emission transitions associated with monomeric
forms of other BODIPY derivatives (i.e., absorption and
emission wavelength maxima (λmax) near 498nm and 506–
515nm, resp.). Me4BODIPY-PC also displays substantial
broadening of its emission spectrum as a function of
increasing ﬂuorophore concentration due to elevated
ﬂuorescence near 570nm relative to the 510–520nm region.
Although the photophysical mechanism accounting for
the emission broadening may diﬀer from the excited state
dimer ﬂuorescence of dimethyl-BODIPY derivatives (see
Discussion and [11]), the response serves as an eﬀective
indicator of Me4BODIPY-PC local concentration and
lateral distribution within lipid monolayers and bilayers.
We recently showed that alterations in Me4BODIPY-PC
packing density in POPC monolayers, achieved by lateral
compression at constant Me4BODIPY-PC mole fraction
or by variation of Me4BODIPY-PC mole fraction, were
detectable in the emission spectra even though correspond-
ing force-area isotherms indicated no deviation from ideal
mixing behavior [11]. The ﬁndings suggested that direct
monitoring of ﬂuorescence spectral changes could provide
a highly sensitive tool for studying lipid lateral interactions
in monolayers. However, to extract the information from
the multiple emission spectra, that is, as many as 600
spectra per isotherm, an eﬀective means is needed to analyze
the data.
When the input data is extremely large and/or contains
redundancy, then transformation into a reduced repre-
sentation provides an eﬀective means for preservation of
essential information. Several data reduction methods are
available [13–17] such as principal component analysis
(PCA), semideﬁnite embedding, partial least square, and
multidimensionalscaling.PCAwasdesignedbyKarlPearson
[16] to compress and identify unknown trends in a mul-
tidimensional data set. Data dimensionality is reduced by
performing a covariance analysis. Herein, we show that PCA
provides an eﬀective way to analyze ﬂuorescence spectra of
binary constituent lipid monolayers. By using this method,
each spectrum can be represented by one point on a plane.
We ﬁnd that points, belonging to the same lipid constituents
and experimental conditions, form a curve on the plane
where each point belongs to a diﬀerent mole fraction.
The location and shape of the curve are characteristics
to the lateral organization of the respective monolayer.
Use of phosphatidylcholine (PC) or sphingomyelin (SM),
containing either saturated-monounsaturated or disaturated
hydrocarbonchains,asthenonﬂuorescentlipidinthebinary
constituent monolayers enables evaluation of the role played
by matrix lipid phase state and composition in controlling
the lateral mixing of the ﬂuorescent lipid by PCA.
2.MaterialsandMethods
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)
and 1,2-dipalmitoylphosphatidylcholine (DPPC) were pur-
chased from Avanti Polar Lipids (Alabaster AL). Palmitoyl
sphingomyelin (PSM) and oleoyl sphingomyelin (OSM)
were produced by reacylation of lyso-SM with the desired
fatty acyl residue and puriﬁed as described previously [18,
19]. 1-Palmitoyl-2-[7-(4, 4-diﬂuoro-1,3,5,7-tetramethyl-4-
bora-3a, 4a-diaza-s-indacene-8-yl)heptanoyl]-sn-glycero-3-
phosphocholine (Me4BODIPY-PC) was synthesized and
puriﬁed as described earlier [20].
2.1. Fluorescence Spectra of Binary-Constituent Lipid Mono-
layers. TheLangmuirﬁlmbalanceplatformwasoutﬁttedfor
acquisitionofﬂuorescenceemissionintensityasafunctionof
wavelength while simultaneously measuring surface pressure
(π) and dipole potential (ΔV) as a function of lipid cross-
sectional molecular area (A) of the lipid monolayer [11,
12]. Brieﬂy, BODIPY lipid ﬁlms were excited at a 90
◦
incident angle using 488nm unpolarized light from an
argon-ion laser (Model 2122-45L, JDS Uniphase, San Jose,
CA) equipped with a model-3 light-intensity controller and
a ﬁber optic coupler (Model HPUC-23-488-S-3, FAC-2BL;
Oz Optics, Nepean, ON, Canada). Fluorescence emission
was collected perpendicular to the interface at a distance
of ∼1cm using a ﬁber optic spectrometer (Model PC2000-
ISA, Ocean Optics, Dunedin, FL) equipped with an L2
lens and 200-μm slit. A 500-nm-long pass ﬁlter (500EFLP,
Omega Optical, Brattleboro, VT) was mounted between the
emission collimator and the detector to reduce scattered
excitation light. Fluorescence emission spectral intensities
were collected each second. Although monolayer compres-
sion was continuous during the spectral data acquisition
cycle, the fractional change in lipid concentration during
eachacquisitioncyclewas ≤0.0073.Controlemissionspectra
were unaﬀected by gas phase, that is, air or argon, or by
0.01% sodium azide in the subphase buﬀer.
Subphase buﬀer was maintained at 24
◦C via a ther-
mostated, circulating water bath and was produced using
water puriﬁed by reverse osmosis, activated charcoal adsorp-
tion, mixed-bed deionization, then passed through a Milli-Q
UV Plus System (Millipore Corp., Bedford, MA), and ﬁltered
through a 0.22μm Millipak 40 membrane. Subphase buﬀer
contained 10mM potassium phosphate (pH 6.6), 100mM
NaCl, and 0.01% NaN3 and was kept stored under argon,
cleaned by passage through a seven-stage series ﬁltration set-
up consisting of an Alltech activated charcoal gas puriﬁer,
a LabClean ﬁlter, and a series of Balston disposable ﬁlters
consisting of two adsorption (carbon) and three ﬁlter units
(93% and 99.99% eﬃciency at 0.1μm). The ﬁlm balance
was housed in an isolated laboratory supplied with clean air
by a Bioclean Air Filtration system equipped with charcoal
and HEPA ﬁlters and was kept under humidiﬁed argon in a
separate enclosure. Other features contributing to isotherm
reproducibility include automated lipid spreading via aInternational Journal of Biomedical Imaging 3
modiﬁed HPLC autoinjector, automated surface cleaning by
multiple barrier sweeps between runs, and highly accurate,
reproducible setting of the subphase level by an automated
aspirator. Glassware was acid cleaned, rinsed with puriﬁed
water, and then with hexane/ethanol (95: 5) before use.
Lipid monolayers were formed by automated
spreading (51.67μL aliquots) of mixtures made from
stock solutions dissolved in toluene/ethanol (5:6) or hex-
ane/isopropanol/water (70: 30: 2.5). After spreading on the
subphasesurfaceandadelayperiodof4min,lipidﬁlmswere
compressed at a rate of ≤4 ˚ A
2/molecule/min. Surface pres-
sure and area calibration of the ﬁlm balance were performed
as detailed previously [21]. Phospholipid concentrations,
including BPC, were determined by a modiﬁed Bartlett
assay [21]. Solvent purity was veriﬁed by dipole potential
measurements using a 210Po ionizing electrode [21].
2.2. Principal Component Analysis of the Fluorescence Spectra.
Here we provide a short description of PCA. The measured
ﬂuorescence spectra can be represented by S,a nnxm matrix,
where m is the number of measured spectra. Each spectrum
is measured at the same n wavelengths. Sij is the intensity of
ﬂuorescence emission measured at the ith wavelength of the
jth spectrum. The covariance matrix C, a symmetric mxm
matrix, can be created from the S matrix as follows:
Cij =
n
k=1(Ski − Mi)

Skj −Mj

n −1
,( 1 )
where Mj =
n
h=1Shj/n is the average intensity of the
jth spectrum. There are m eigenvalues and m respective
eigenvectors for the covariance matrix. The eigenvalues of
C are real positive numbers and are sorted in descending
order in the eigenvalue vector, Λ.F r o mt h ee i g e n v e c t o r s ,o n e
can create an mxm matrix, V where each column represents
an eigenvector. In V, the eigenvectors are sorted as in Λ,
that is, the eigenvector the eigenvector in the ﬁrst column
has the largest eigenvalue; in the second column, the next
largest eigenvalue, and so forth . By multiplying the S and V
matrices and transposing the product, one obtains the mxn
ﬁnal data matrix, P = (SV)T. We refer to the rows of the ﬁnal
data matrix as principal vectors. The kth element of the ith
principal vector is
Pik =
m 
h=1
SkhVhi. (2)
In the case of our spectra, the ﬁrst two eigenvalues
in Λ are much larger than the rest of the eigenvalues, as
shown in Table 2.T h u se a c hﬂ u o r e s c e n ts p e c t r u mc a nb e
approximated by the linear combination of the ﬁrst two
principal vectors, that is
Skj ≈ Mj +Vj1P1k +Vj2P2k,( 3 )
or if the intensity of each spectra at the ﬁrst wavelength is
zero, S1j = 0, then
Skj = Skj − S1j ≈ Vj1(P1k −P11)+Vj2(P2k −P21). (4)
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Figure 1: Experimental set-up and structures of lipids investigated.
Upper panel depicts a Langmuir surface balance modiﬁed to acquire
ﬂuorescence emission spectra of lipids forming a monolayer at the
air/water interface. γ0 = surface tension of gas/water interface; γ
= surface tension of gas/water interface covered by lipid; (γ0-γ)
= surface pressure. Lower panel shows the structures of the lipids
studied. The following color scheme applies: gray = carbon, red
= oxygen, blue = nitrogen, orange = phosphorus, pink = boron,
aqua = ﬂuorine. Arrows pointing left indicate cis double bonds and
arrows pointing right equal trans double bonds.
3. Results
Fluorescence spectra of lipid monolayers containing
Me4BODIPY-PC as one of the two lipid constituents
were acquired while simultaneously measuring the surface
pressure versus average molecular area isotherm (Figure 1,
upper panel). In every case, Me4BODIPY-PC was one
lipid constituent (Figure 1, lower panel), while the type
and amount of the second lipid constituent (POPC,
DPPC, OSM, and PSM) varied. This experimental strategy
provided insights into the eﬀects of lipid phase state and
composition on Me4BODIPY-PC lateral mixing. Figure 2
serves as an example, showing the ﬂuorescence spectra
of Me4BODIPY-PC/POPC (Figures 2(a) and 2(c))a n d
Me4BODIPY-PC/DPPC (Figures 2(b) and 2(d))m o n o l a y e r s
obtained at two representative surface pressures of 5
and 30mN/m. It is noteworthy that surface pressures
in the 30–35mN/m region mimic conditions found in
biomembranes [22, 23]. For each panel in Figure 2, the four
spectra correspond to the following Me4BODIPY-PC mole
fractions: 0.01 (red), 0.1 (blue), 0.2 (green), 1 (black).
Interpretation of the Me4BODIPY-PC spectral responses
in Figure 2 is facilitated by consideration of the phase4 International Journal of Biomedical Imaging
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Figure 2: Fluorescence spectra of binary-constituent lipid monolayers containing BODIPY-labeled phosphatidylcholine. Fluorescence
emissionintensityofBODIPY-labeledPCisplottedagainstemissionwavelength.(a)Me4BODIPY-PC/POPCmonolayersat30mN/mlateral
pressure; (b) Me4BODIPY-PC/DPPC monolayers at 30mN/m, (c) Me4BODIPY-PC/POPC monolayers at 5mN/m, (d) Me4BODIPY-PC-
/DPPC monolayers at 5mN/m. Color codes: 1% Me4BODIPY-PC (red), 10% Me4BODIPY-PC (blue), 20% Me4BODIPY-PC (green), 100%
Me4BODIPY-PC (black).
behavior of the lipids comprising the binary-constituent
lipid monolayers. POPC and Me4BODIPY-PC both are
known to display ﬂuid phase behavior at all surface pressures
below monolayer collapse (e.g., ∼45mN/m), while DPPC
displays ﬂuid phase behavior only at low surface pressures
(e.g., <∼8mN/m ) and undergoes a two-dimensional phase
transition resulting in ordered lipid hydrocarbon chains
at high surface pressures (e.g., [11, 18, 24]). At 5mN/m
(Figures 2(c) and 2(d)), both lipid constituents display
ﬂuid-phase behavior and the emission spectra are similar
in intensity and shape at equivalent Me4BODIPY-PC mole
fractions.However,at30mN/m(Figures2(a)and2(b)),only
Me4BODIPY-PC and POPC remain ﬂuid; whereas, DPPC
is gel-like and chain ordered [11, 18, 24]. Under the latter
condition, dramatic changes are observed in Me4BODIPY-
PC/DPPC spectral intensity and shape, that is, quenching
and broadening, compared to equivalent Me4BODIPY-PC
mole fractions in the Me4BODIPY-PC/POPC mixed mono-
layers.
With BODIPY ﬂuorophores, dilute noninteracting
monomers exhibit a narrow emission peak centered in
the 506–515nm range after excitation [11, 12, 25–27].
At suﬃciently high BODIPY concentrations, additional
absorption and emission peaks are observed, often reﬂecting
dimer emission and/or homo resonance energy transfer
(F¨ orster distance = 57 ˚ A). Johansson and colleagues haveInternational Journal of Biomedical Imaging 5
Table 1: Compositions and experimental conditions of binary-constituent lipid monolayers.
5mN/m 75˚ A
2/molecule 30mN/m 64 ˚ A
2/molecule
Me4BODIPY-PC/POPC 1% 1% 1% 1%
Me4BODIPY-PC/POPC 10% 10% 10% 10%
Me4BODIPY-PC/POPC 20% 20% 20% 20%
Me4BODIPY-PC/DPPC 1% 1% 1% 1%
Me4BODIPY-PC/DPPC 10% 10% 10% 10%
Me4BODIPY-PC/DPPC 20% 20% 20% 20%
Me4BODIPY-PC/18:1-SM 1% 1% 1% 1%
Me4BODIPY-PC/18:1-SM 10% 10% 10% 10%
Me4BODIPY-PC/18:1-SM 20% 20% 20% 20%
Me4BODIPY-PC/16:0-SM 1% 1% 1% 1%
Me4BODIPY-PC/16:0-SM 10% 10% 10% 10%
Me4BODIPY-PC/16:0-SM 20% 20% 20% 20%
Me4BODIPY-PC 100% 100% 100% 100%
% indicates Me4BODIPY-PC mole%.
The ﬁrst and third columns represent surface pressure.
The second and fourth columns represent cross-sectional molecular area.
Table 2: First six eigenvalues of the covariance matrix.
λ1 λ2 λ3 λ4 λ5 λ6
2,264,835 158,654 594 316 192 52
shown that emission of ground-state dimethyl-BODIPY
dimers, denoted DII (J-dimer) occurs when the BODIPY
rings are oriented in planes with their S0 → S1 transition
dipoles aligned at ∼ 55
◦. DII dimers absorb near 570nm
and emit near 630nm [25]. Energy transfer to the ground-
state DII dimers from excited-state monomers is typically
responsible for the DII emission peak observed near 630nm.
A second type of ground-state dimer, denoted DI (H-dimer)
and characterized by sandwich-like stacking of the BODIPY
rings, results in parallel alignment of the transition dipoles
and absorption near 477nm, but produces no ﬂuorescence
emission after excitation [25, 26]. In the case of Me4-
BODIPY-PC, we ﬁnd no evidence of the 620–630nm peak
characteristic of dimethyl-BODIPY dimer ﬂuorescence but
rather the presence of an emission shoulder (∼570nm) at
high Me4BODIPY-PC surface concentrations. Substantial
spectral broadening occurs because of increased ﬂuorescence
near 570nm relative to the 510–520nm region. Thus,
detection of surface concentration changes and lateral
heterogeneity in the mixing of Me4BODIPY-PC in lipid
monolayers and bilayers becomes evident.
In addition to formation of the emission shoulder,
intensity decreases occur in the ∼510nm emission peaks at
2 0m o l e %c o m p a r e dt o1 0m o l e %M e 4BODIPY-PC (Figures
2(a), 2(c),a n d2(d)). This response could reﬂect nonﬂu-
orescent relaxation occurring for excited monomers by a
mechanisminvolvingF¨ orsterenergytransferbetweenexcited
state monomer and ground state dimers aligned diﬀerently
than DII dimers [25, 26]. In contrast to the above cases,
the spectra in Figure 2(b) are broad at every Me4BODIPY-
PC mole fraction, that is, ﬂuorophore dimers form even at
very low probe concentration, suggesting highly nonideal
mixingandpossiblelateralphaseseparationofMe4BODIPY-
PC in the DPPC monolayers at 30mN/m (Figure 2(b)).
Under such conditions, the speciﬁc area of Me4BODIPY-PC
(30mN/m; 80 ˚ A
2/molecule) [11] is considerably larger than
theDPPCspeciﬁcarea(46.2 ˚ A
2/moL)[18,24].Me4BODIPY-
PC molecules are unable to ﬁt into the tight lattice of DPPC
molecules. Breaking this lattice structure at many points is
not energetically feasible. Thus, even at low concentration,
Me4BODIPY-PC molecules are expected to segregate, form-
ing clusters in the monolayer. In the clusters, the local probe
concentration is high, where dimers (or excimers) may form
[25–28], resulting in spectral broadening (Figure 2(b);r e d
curve). The preceding discussion of spectral and force-area
data facilitates interpretation of the results of the principal
component analyses that follow.
In general, analogous monolayer phase behavior is
exhibited by 18:1 sphingomyelin (SM) as by POPC in that
18:1-SM remains ﬂuid at all surface pressures. However, at
30mN/m, 16:0 SM exists as a mixture of coexisting gel-
like chained-ordered and ﬂuid chain-disordered phases, in
contrast to DPPC which exists as a gel-like, chain-ordered
phase (e.g, [18, 24]). It is noteworthy that the spectra
of Me4BODIPY-PC/18:1-SM and Me4BODIPY-PC/16:0-SM
(not shown) are broadened at surface pressures of 5 and
30mN/maswellasataveragemolecularcross-sectionalareas
of 64 ˚ A
2/molecule and 75 ˚ A
2/molecule with increasing probe
concentration, reﬂecting subtle diﬀerences in lipid structure.
Table 1 shows that a total of 52 ﬂuorescence spectra
were simultaneously analyzed by PCA using the spectra
of 13 binary mixtures taken at two lateral pressures and
two speciﬁc areas. We determined the eigenvalues and
eigenvectorsoftherespective52×52covariancematrix,C,by
reducing the symmetric matrix to tridiagonal form [16, 17].
The ﬁrst six elements of the sorted eigenvalue vector, Λ,a r e
shown in Table 2.6 International Journal of Biomedical Imaging
Since the ﬁrst two eigenvalues are much larger than
the rest of the 52 eigenvalues, one is able to characterize
each ﬂuorescence spectrum by only the ﬁrst two principal
vectors (ﬁrst two rows of the ﬁnal data matrix, P). This is
a massive dimensionality reduction from 52 to 2. In Figure 3,
the components of the ﬁrst two principal vectors are plotted
against the respective wavelengths. The ﬁrst principal vector
(red curve) shows strong similarity to spectra measured at
low Me4BODIPY-PC mole fractions with the exception of
the spectrum (red curve) shown in Figure 2(b).T h ep e a k
location (510nm) of the ﬁrst principal vector and its half
width (40nm) are similar to that of spectra taken at 1
mole% Me4BODIPY-PC concentration in Figures 2(a), 2(c),
and 2(d). As was pointed out above, these spectra originate
from ﬂuorescence emission of the excited monomer probe.
The second principal vector (Figure 2, blue curve) resembles
higher-order ﬂuorescence, that is, dimer or excimer, because
it peaks at 572nm where the spectral shoulder appears
at high Me4BODIPY-PC concentrations. Note that each
spectrum taken at high Me4BODIPY-PC concentration is
expected to result in both monomer and dimer (or excimer)
ﬂuorescence because dimer formation from monomers is a
reversible interaction [25–28].
In order to demonstrate the validity of the PCA
approach, the measured intensities of the 52 ﬂuorescence
spectra were plotted against the calculated intensities using
(4)( Figure 4). A straight line could be ﬁtted to the 52×2048
points with high conﬁdence. The slope and the intercept
of the ﬁtted line are 1.0002 ± 0.00008 and −0.043 ± 0.018,
respectively, while the correlation coeﬃcient of the ﬁt is
0.9997. Consequently, the spectra of BODIPY-labeled, two-
constituent lipid monolayers can be approximated by the
linear combinations of the ﬁrst two principal vectors given
by (4).
In the case of the jth spectrum, the coeﬃcients of
the linear combinations are the jth elements of the ﬁrst
two eigenvectors, Vj1 and Vj2. There is a strong positive
correlation between the value of Vj1 and the peak height of
the jth spectrum, while Vj2 correlates with the half-width
of the spectrum. In Figure 5(a), the elements of the ﬁrst
eigenvector are plotted against the respective peak height.
The correlation coeﬃcient between Vj1 and the peak height
is0.96.InFigure 5(b),theelementsofthesecondeigenvector
are plotted against the half-width of the respective spectrum.
The correlation coeﬃcient between Vj2 and the half-width
is 0.91. Note that in Figure 5(b), the point that deviates
most from the general trend, with coordinates (261,0.5),
belongs to the spectrum of pure Me4BODIPY-PC monolayer
at 30mN/m.
4. Discussion
According to (4), the jth elements of the ﬁrst two eigen-
vectors, Vj1 and Vj2, fully specify the jth spectrum, while
the ﬁrst two principal vectors are characteristics of all the
measured spectra. Thus, geometrically each spectrum can be
represented by one point in a plane with coordinate axes:
α and β. For example, in the case of the jth spectrum, the
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Figure 3: First two principal vectors of 52 ﬂuorescence spectra. The
elements of the ﬁrst two principal vectors, P1k and P2k,r e s p e c t i v e l y ,
are plotted against the 2048 wavelengths where each of the 52
ﬂuorescence spectra was measured. Each measured spectrum can
be approximated by the linear combination of these two curves (see
(4)). The ﬁrst and second principal vectors are marked by red and
blue dots, respectively.
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Figure 4: Comparison of reconstructed spectral intensities with
experimental intensities. Experimental intensities from 52 ﬂuo-
rescence spectra are plotted against calculated intensities. The
calculation is based on an equation, Equation (4), containing the
ﬁrst two principal vectors. The plot contains 52×2048 points. Each
measuredspectrawasshiftedtogetzeroaverage intensityattheﬁrst
50 wavelengths.
coordinates of the respective point are α = Vj1 and β = Vj2.
Figures 6(a), 6(b), 6(c),a n d6(d) show the (α,β) planes with
points representing diﬀerent spectra, measured at surface
pressuresof5mN/mand30mN/m,andataveragemolecular
cross-sectional areas of 75 ˚ A
2/molecule and 64 ˚ A
2/molecule,International Journal of Biomedical Imaging 7
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Figure 5: Correlations between eigenvector elements and spectral
characteristics. (a) Elements of the ﬁrst eigenvector of the covari-
ance matrix Vj1 are plotted against the peak height of the respective
spectrum. The slope and intercept of the ﬁtted straight line are 1.1·
10−4±4.5·10−6 and0.012±0.005.Thecorrelationcoeﬃcientis0.96.
(b)Elementsofthesecondeigenvector ofthecorrelationmatrixVj2
are plotted against the half-width of the respective spectrum. The
slope and intercept of the ﬁtted straight line are 0.0019 ± 0.00012
and −0.229 ±0.017. The correlation coeﬃcient is 0.91.
respectively. In each panel, points belonging to monolay-
ers containing the same lipid constituents are connected
by the same color line: Me4BODIPY-PC/POPC (black);
Me4BODIPY-PC/DPPC (green); Me4BODIPY-PC/18:1-SM
(blue); Me4BODIPY-PC/16:0-SM (red). The zig-zag nature
of the line connecting the points illustrates how the charac-
teristic point representing the spectrum travels as the mole
fraction of Me4BODIPY-PC increases. When the probe’s
mole fraction approaches zero, the characteristic point of
each line is expected to approach the origin (α = 0, β = 0).
This is the case because, with decreasing Me4BODIPY-PC
concentration, the ﬂuorescence intensity at any wavelength
approaches zero, Skj → 0, and thus in (4), both Vj1 and Vj2
should approach zero. (Note that the principal vectors are
independent of the Me4BODIPY-PCconcentration.)Thusin
spite of the fact that there is no spectrum at zero ﬂuorophore
concentration, each line can be expected to start from the
origin.
It was pointed out above that the β and α coordinates
of the characteristic point correlate with the half-width
and height of the spectrum, respectively, and these spectral
properties depend on dimer (or excimer) formation by the
ﬂuorophore. Since the ﬂuorescence spectrum depends on
the surface concentration, that is, mole fraction, of the
ﬂuorescent lipid in the respective monolayer, one can expect
the location and shape of the lines in the (α,β)p l a n et o
reﬂect changes in Me4BODIPY-PC surface concentration
and lateral organization. It is noteworthy that two distinctly
diﬀerent line shapes are observed in Figure 6.
(1) The initial slope of the line is negative, starting from
zero ﬂuorophore content, if the monolayer is in ﬂuid
or ﬂuid/gel mixed phase. This situation occurs for all
lipids shown in Figure 6, except for the green curve
(DPPC)inFigure 6(b)(30mN/m).Atlow-molefrac-
tion, the Me4BODIPY-PC is expected to mix ideally
with the ﬂuid phase lipids and to be monomer-
ically dispersed. With increasing ﬂuorophore con-
centration, the number of monomers increases (i.e.,
the peak height and α increases), and the half-
width of the spectrum slightly decreases (i.e., β
decreases). Between 10 and 20 mole% Me4BODIPY-
PC, dimers are expected to substantially increase in
the monolayer, resulting in an emission shoulder at
570nm (i.e., the half-width and β increases). On
the other hand, dimer formation makes possible
nonﬂuorescent energy transfer between excited state
monomer and ground state dimer (i.e., the peak
height and α decreases).
(2) The initial slope of the line is positive, starting from
zero ﬂuorophore content, if the monolayer is in gel
phase (Figure 6(b),g r e e nc u r v e ) .E v e na tl o w - m o l e
fraction, Me4BODIPY-PC mixes nonideally with gel
phase DPPC, and forms aggregates. Thus increasing
monomer and dimer ﬂuorescence can be detected
simultaneously from low-ﬂuorophore concentration,
that is, α and β increase simultaneously with increas-
ing peak height and half-width. The response sug-
gests that dimer abundance can be aﬀected by the
lipid lateral organizational state.
5. Conclusion
Under ﬂuid-phase monolayer conditions, curves are highly
similar for same-type lipids (e.g., POPC and DPPC; OSM
and PSM). Nonetheless, detectable diﬀerences exist between
the lipid types, consistent with subtle diﬀerences in the
lateral mixing of Me4BODIPY-PC in each lipid type. The
diﬀerences in curves generated from spectra acquired at
30mN/m imply that both lipid type and phase state aﬀect
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Figure 6: 2D-Diagram of ﬂuorescence spectra of binary-constituent lipid monolayers. Each point on the (α,β) plane represents a
ﬂuorescence spectrum of a BODIPY-labeled binary-constituent lipid monolayer. For the jth spectrum α = Vj1 and β = Vj2,w h e r eVj1
and Vj2 are jth component of the 1st and 2nd eigenvectors, respectively. A zig-zag line of the same color connects points belonging to
monolayers comprised of the same lipid constituents. These lines start from the origin representing the spectra of diﬀerent monolayers with
0 of the monolayer increases with successive dots corresponding to Me4BODIPY-PC mole fractions of 0.01, 0.1, and 0.2. All lines converge to
the same ﬁnal point, representing the spectrum of pure Me4BODIPY-PC monolayer. Panels (a) and (b) represent lateral pressures of 5 and
30mN/m; whereas, panels (c) and (d) correspond to average cross-sectional molecular areas of 75 and 64 ˚ A
2/molecule, respectively. Color
codes: Me4BODIPY-PC/POPC (black), Me4BODIPY-PC/DPPC (green), Me4BODIPY-PC/18:1SM (blue), Me4BODIPY-PC/16:0SM (red).
The dotted ellipses encircle equivalent Me4BODIPY-PC mole fractions, with the numerical label indicating the ﬂuorophore mole fraction
(0.01, 0.1, or 0.2) mixed with each of the four diﬀerent nonﬂuorescent lipids (POPC, DPPC, 18:1-SM, or 16:0-SM).
conditions approximating biomembranes. Currently under-
way are comprehensive studies involving: (1) more lipid
mixing ratios, (2) diﬀerent BODIPY-labeled lipids, and (3)
other nonﬂuorescent lipid components.
Collectively, our data demonstrate the usefulness of PCA
for deciphering ﬂuorescence spectra obtained from lipid
monolayers with respect to the lateral distribution of lipid
ﬂuorophore. The exceptional promise shown by PCA for
handling large spectral data sets, the nanoscale resolution
aﬀorded by the ﬂuorescence signal, and the inherent versa-
tility of lipid monolayers for characterization of lipid lateral
interactions combine to provide a new approach expected to
facilitate investigation of lipid lateral organizational changes
induced by diﬀering lipid compositions and by proteins.
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